When.com Web Search

  1. Ad

    related to: pain reassessment after iv medication therapy for osteoporosis

Search results

  1. Results From The WOW.Com Content Network
  2. Pain assessment - Wikipedia

    en.wikipedia.org/wiki/Pain_assessment

    The Joint Commission began setting standards for pain assessment in 2001 stating that the route of analgesic administration dictates the times for pain reassessment, as different routes require different amounts of time for the medication to have a therapeutic effect. Oral: 45–69 minutes. Intramuscular: 30 minutes.

  3. Medication-related osteonecrosis of the jaw - Wikipedia

    en.wikipedia.org/wiki/Medication-related_osteo...

    Exposed bone after extraction, pain: Complications: Osteomyelitis of the jaw: Usual onset: After dental extractions: Duration: Variable: Types: Stage 1-Stage 3: Causes: Medications related to cancer therapy, and osteoporosis in combination with dental surgery: Risk factors: Duration of anti-resorptive or anti-angiogenic drugs, intravenous vs by ...

  4. Zoledronic acid - Wikipedia

    en.wikipedia.org/wiki/Zoledronic_acid

    These include osteoporosis, high blood calcium due to cancer, bone breakdown due to cancer, Paget's disease of bone [3] and Duchenne muscular dystrophy (DMD). It is given by injection into a vein. [3] Common side effects include fever, joint pain, high blood pressure, diarrhea, and feeling tired. [3]

  5. Steroid-induced osteoporosis - Wikipedia

    en.wikipedia.org/wiki/Steroid-induced_osteoporosis

    The International Osteoporosis Foundation and the European Calcified Tissue Society recommend pharmacological therapy for osteoporosis in postmenopausal women and men ≥70 years, with a previous fragility fracture, or a dose equivalent of prednisone ≥7.5 mg daily for ≥3 months. For premenopausal women and men <50 years taking steroids for ...

  6. Bisphosphonate - Wikipedia

    en.wikipedia.org/wiki/Bisphosphonate

    Long-term treatment with bisphosphonates produces anti-fracture and bone mineral density effects that persist for 3–5 years after an initial 3–5 years of treatment. [2] The bisphosphonate alendronate reduces the risk of hip, vertebral, and wrist fractures by 35-39%; zoledronate reduces the risk of hip fractures by 38% and of vertebral ...

  7. Denosumab - Wikipedia

    en.wikipedia.org/wiki/Denosumab

    Denosumab, sold under the brand name Prolia among others, is a human monoclonal antibody used for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone. [21] [22] The most common side effects are joint and muscle pain in the arms or legs. [23]

  8. Extravasation (intravenous) - Wikipedia

    en.wikipedia.org/wiki/Extravasation_(intravenous)

    Extravasation is the leakage of intravenously (IV) infused, and potentially damaging, medications into the extravascular tissue around the site of infusion. The leakage can occur through brittle veins in the elderly, through previous venipuncture access, or through direct leakage from wrongly positioned venous access devices.

  9. Romosozumab - Wikipedia

    en.wikipedia.org/wiki/Romosozumab

    Romosozumab, sold under the brand name Evenity (/ ɪ ˈ v ɛ n ɪ t i / ih-VENN-ih-tee or with the pin-pen merger, / ɪ ˈ v ɪ n ɪ t i / ih-VINN-ih-tee), is a medication used to treat osteoporosis. [7] [8] It has been found to decrease the risk of fractures of the spine. [7] Common side effects include headache, joint pain, and injection site ...